explore -WSS

explore

author：explore 2025-09-01 15:19:29 - browse：962

insulin biosimilar — The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests. Jacquelyn Martin/AP

A group representing clinical labs across the country sued the Food and Drug Administration on Wednesday over the agency’s plan to actively regulate lab-developed tests.

The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests. When the FDA finalized its test regulation plan last month, several experts said it was only a matter of time until someone in the lab industry sued.

Tests made in labs have historically gone unregulated by the FDA, as the agency considered them low-risk when it started regulating medical devices in 1976. But the tests have since become more numerous and complex, and the regulatory gray area enabled unreliable tests to thrive and harm patients. Infamous examples include Theranos’ blood tests, as well as misleading prenatal genetic tests from a range of companies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Weight loss drugs should be covered by insurers, AMA says

WSS

CVS, Rite Aid closures threaten to worsen pharmacy deserts

FDA's naming rule on biosimilars has undermined competition

Healthy food access boosts outcomes in two studies

Weight loss drugs should be covered by insurers, AMA says

Decaf coffee targeted by food safety group under obscure FDA rule

Scientists boost immune system in aging mice by making it youthful

knowledge

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Wikipedia

Walensky prepares to leave CDC — and Congress — behind

Carbon Health diabetes program, a test of data

Cancer drug shortages should be causing more outrage

Decaf coffee targeted by food safety group under obscure FDA rule

Sports medicine is finally prioritizing gender equality

Cancer diagnosis changes perspective doctor, former hospital CEO

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Vertex Pharmaceuticals may move headquarters in Boston

Walensky prepares to leave CDC — and Congress — behind

Patient advocates debate FDA's accelerated approval process

Wikipedia

Cancer diagnosis changes perspective doctor, former hospital CEO

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

Steward Health Care has deal to sell doctor network to UnitedHealth

Experimental asthma app from Apple and Anthem shows promise

Today's health inequities arise from racist U.S. history, say experts

Will generative AI in health care meet the fate of IBM's Dr. Watson?

entertainment

hotspot

hotspot

hotspot